SCHEMBL6972846

SCHEMBL6972846

CC(C)c1nc(COC(N)=O)n(Cc2ccc(N)cc2)c1Sc1cc(Cl)cc(Cl)c1

nearest known ligand 0.34

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
P2RX3 P56373 8/20 0.34
TBXA2R P21731 2/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HSD17B10 Q99714 1/20 0.31
ALOX5 P09917 2/20 0.31
ALOX5AP P20292 2/20 0.31
TDP1 Q9NUW8 1/20 0.31
CCR5 P51681 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14001658 0.93 P2RX3 (0.35) P2RX3TBXA2RTP53MAPTTDP1
SCHEMBL13996465 0.93 P2RX3 (0.41) P2RX3KDM4EALDH1A1SMN1; SMN2
SCHEMBL6967638 0.91 TDP1 (0.39) P2RX3TP53MAPTALDH1A1TDP1
SCHEMBL6975100 0.91 TDP1 (0.33) P2RX3TP53MAPTHPGDSMN1; SMN2
SCHEMBL6966285 0.91 P2RX3 (0.33) P2RX3KDM4EALDH1A1HPGDSMN1; SMN2
Capravirine SCHEMBL40347 0.91 PIM1 (0.35) P2RX3MAPTKDM4EALDH1A1SMN1; SMN2
Capravirine SCHEMBL4656686 0.91 PIM1 (0.35) P2RX3MAPTKDM4EALDH1A1SMN1; SMN2
SCHEMBL14439871 0.90 P2RX3 (0.33) P2RX3MAPT
SCHEMBL6973048 0.90 ENPP2 (0.35) P2RX3TBXA2RALDH1A1SMN1; SMN2CCR5
SCHEMBL14439866 0.89 L3MBTL1 (0.38) TBXA2RTP53MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070190523-A1 Method and compositions for identifying anti-hiv therapeutic compounds GILEAD SCIENCES, INC. 2007-08-16 US disclosed
US-20070190523-A1 Method and compositions for identifying anti-hiv therapeutic compounds GILEAD SCIENCES, INC. 2007-08-16 US disclosed
EP-0786455-B1 IMIDAZOLE DERIVATIVE SHIONOGI & CO (JP) 2003-12-03 EP disclosed
US-6147097-A METHOD FOR TREATING AIDS SHIONOGI & CO., LTD. (JP) 2000-11-14 US disclosed
US-5910506-A IMIDAZOLE DERIVATIVES, E.G.5-(3,5-DICHLOROPHENYLTHIO)-1,2-DIMETHYL-4-ISOPROPYL-1H-IMIDAZOLE; VIRICIDES; AIDS; NONTOXIC SHIONOGI & CO., LTD. (JP) 1999-06-08 US disclosed
EP-0786455-A1 IMIDAZOLE DERIVATIVE SHIONOGI & CO., LTD. (JP) 1997-07-30 EP disclosed